- 专利标题: Methods and reagents for assessing the presence or absence of replication competent virus
-
申请号: US16966414申请日: 2019-01-31
-
公开(公告)号: US11535903B2公开(公告)日: 2022-12-27
- 发明人: Ruth Berry , Edwin Webb
- 申请人: Juno Therapeutics, Inc.
- 申请人地址: US WA Seattle
- 专利权人: Juno Therapeutics, Inc.
- 当前专利权人: Juno Therapeutics, Inc.
- 当前专利权人地址: US WA Seattle
- 代理机构: Morrison & Foerster LLP
- 国际申请: PCT/US2019/016194 WO 20190131
- 国际公布: WO2019/152747 WO 20190808
- 主分类号: C12Q1/70
- IPC分类号: C12Q1/70 ; C12Q1/6851 ; C12Q1/686 ; C07K14/16
摘要:
Provided are methods of detecting replication competent virus, e.g., replication competent retrovirus such as gammaretrovirus or lentivirus, in a sample containing a cell transduced with a viral vector particle encoding a recombinant and or heterologous molecule, e.g., heterologous gene product. The methods may include assessing transcription of one or more target genes, such as viral genes, that are expressed in a retrovirus but not expressed in the viral vector particle. Replication competent retrovirus may be determined to be present if the levels of RNA of the one or more target genes is higher than a reference value, which can be measured directly or indirectly, including from a positive control sample containing RNA from the respective target gene at a known level and/or at or above the limit of detection of the assay.
公开/授权文献
信息查询